Friess Associates LLC Collegium Pharmaceutical, Inc Transaction History

Friess Associates LLC

  • $59.9 Million
  • Q2 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021
SELL
$17.83 - $22.29 $2.38 Million - $2.98 Million
-133,594 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$15.78 - $20.82 $121,001 - $159,647
7,668 Added 6.09%
133,594 $2.78 Million
Q2 2020

Aug 14, 2020
BUY
$15.49 - $23.51 $1.95 Million - $2.96 Million
125,926 New
125,926 $2.2 Million

Others Institutions Holding COLL

# of Institutions
254
Shares Held
36.9M
Call Options Held
100K
Put Options Held
21.1K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.12B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Friess Associates LLC Portfolio

Follow Friess Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Friess Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Friess Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email